>
"No More Mr. Nice Guy": Trump Sends Witkoff To Pakistan For U.S.-Iran Talks...
The Lyrid meteor shower is visible now and peaking soon. Here's how to spot it
Expert Guts Claims That HPV Vaccine Reduces Cancer Risk
Trump just put six chemical, fertilizer, and oil executives on the EPA's Science Advisory Board.
Researchers Turn Car Battery Acid and Plastic Waste into Clean Hydrogen and New Plastic
'Spin-flip' system pushes solar cell energy conversion efficiency past 100%
A Startup Has Been Quietly Pitching Cloned Human Bodies to Transfer Your Brain Into
DEYE 215kWh LiFePO4 + 125,000W Inverter + 200,000W MPPT = Run A Factory Offgrid!!
China's Unitree Unveils Robot With "Human-Like Physique" That Can Outrun Most People
This $200 Black Shaft Air Conditions Your Home For Free Forever -- Why Is It Banned in the U.S.?
Engineers have developed a material capable of self-repairing more than 1,000 times,...
They bypassed the eye entirely.
The Most Dangerous Race on Earth Isn't Nuclear - It's Quantum.

In an interview on the "Slobodni Podcast," Tomljenovi? said safety and efficacy claims are unsubstantiated, and the benefits of the vaccine do not outweigh the risks.
Public health policy should rest on solid, transparent evidence — not slogans, not marketing and not selective readings of scientific reviews, biochemist Lucija Tomljenovi?, Ph.D., said recently.
In a wide-ranging interview on the "Slobodni Podcast," Tomljenovi? challenged the evidence base for HPV vaccination programs.
She told host Andrija Klari? that safety and efficacy claims are unsubstantiated, and the benefits of the vaccine do not outweigh the risks.
The widely circulated claim that the HPV vaccine dramatically reduces cervical cancer risk — by as much as 80% if administered before age 16 — collapses under closer examination.
Tomljenovi? has published more than a dozen papers on the HPV vaccine. She was also an expert witness in litigation against Merck, maker of the Gardasil HPV vaccine. In that role, she presented a systematic critique of the claims that the HPV vaccine prevents cancer.
She also delivered an overview of the science on the adverse events associated with the shot, and she presented evidence that Merck manipulated regulators and legislators to grow the market for its vaccine.
Claims that HPV vaccine reduces cancer risk based on flawed Cochrane reviews
Tomljenovi? explained for "Slobodni" listeners why the 2025 Cochrane reviews on HPV vaccines — widely cited by health authorities and the media to support the claim that the vaccine reduces cervical cancer incidence by up to 80% — are flawed.
She said the reviews' own data undermine their conclusions.
The Cochrane Library is often regarded as the gold standard of systematic reviews, she said. Mainstream health institutions often base recommendations on findings from Cochrane.
However, systematic reviews are only as reliable as the studies they include, she said.
According to Tomljenovi?'s analysis of the 300-plus-page review, the majority of epidemiological studies cited to show the vaccine's effects — including its ability to stop invasive cervical cancer — had serious or critical risk of bias, according to the ratings of Cochrane's own reviewers.